Navigation Links
MMX in Medical News

Santarus to Webcast Analyst Day and Investor Briefing Presentation on May 13

...ent, Commercial Operations, Santarus, Inc. mmx (R) Technology - The Benefits of Targeted Deliv...rohn's and Colitis Organization Budesonide mmx (R) - Clinical Development Program in Ulcerative ...g Center for Travelers' Health Rifamycin SV mmx (R) - Clinical Development Program in Traveler'...

Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal

...y ulcerative colitis treatment that utilizes MMX(R) Technology. Lialda with mmx Technology combines a pH dependent gastro-resistant coating, which delays t...ialization rights in Italy. Cosmo Pharmaceuticals SpA, Milan, developed the mmx technology. For further information please contact: Investor Relatio...

Shire Launches Patient Education Forums on Better Managing the Challenges of Ulcerative Colitis

...y ulcerative colitis treatment that utilizes MMX(R) Technology. LIALDA with mmx Technology combines a pH dependent gastro-resistant coating, which delays t...ialization rights in Italy. Cosmo Pharmaceuticals SpA, Milan, developed the mmx technology. Important Safety Information for LIALDA LIALDA tablets are ...

Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives

...tment that utilizes MMX(R) Technology. LIALDA with mmx Technology combines a pH dependent gastro-resistan...y. Cosmo Pharmaceuticals SpA, Milan, developed the mmx technology. Important Safety Information for LIA...ani and Shire Pharmaceuticals. Cosmo's proprietary mmx technology is at the core of the company's product...

LIALDA demonstrates prolonged release of mesalamine in an in vitro study using a simulated colon

...on, with a tablet core containing mesalamine with hydrophilic and lipophilic excipients. LIALDA is the only ulcerative colitis treatment that utilizes mmx Technology. In two pivotal phase III clinical studies, LIALDA was shown to be superior to placebo in inducing remission and treating the symptoms ...
MMX in Medical Technology

Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea

-- Primary endpoint achieved -- LAINATE, Italy - July 4, 2007 - Cosmo Pharmaceuticals SpA (SWX:COPN) announced today positive preliminary results from its phase II/III study with CB-01-11 (Rifamycin SV MMX(tm)) in infectious diarrhoea. CB-01-11 is a broad spectrum, semi-synthetic antibiotic that...

Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW

...y ulcerative colitis treatment that utilizes MMX(R) Technology. LIALDA with mmx Technology combines a pH dependent gastro-resistant coating, which delays t...ialization rights in Italy. Cosmo Pharmaceuticals SpA, Milan, developed the mmx technology. SHIRE PLC Shire's strategic goal is to become the leading s...

New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG

...tment that utilizes MMX(R) Technology. LIALDA with mmx Technology combines a pH dependent gastro-resistan...y. Cosmo Pharmaceuticals SpA, Milan, developed the mmx Technology. For more information about LIALDA and...ani and Shire Pharmaceuticals. Cosmo's proprietary mmx Technology is at the core of the company's product...

Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many Aspects of Daily Life

...new formulation in this class to be approved since 2000. LIALDA is the only ulcerative colitis treatment that utilizes MMX(TM) Technology. LIALDA with mmx Technology combines a pH dependent gastro-resistant coating, which delays the release of the medication to the colon (the site of the inflammation in ...

Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term Safety Study of Lialda (mesalamine) Presented at DDW

...new formulation in this class to be approved since 2000. LIALDA is the only ulcerative colitis treatment that utilizes MMX(TM) Technology. LIALDA with mmx Technology combines a pH dependent gastro-resistant coating, which delays the release of the medication to the colon (the site of the inflammation in ...
MMX in Biological Technology

Shire and TAP Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine For Patients With Active, Mild to Moderate Ulcerative Colitis

...ally the patient population who may benefit most." Once-daily LIALDA with mmx technology contains the highest mesalamine dose per tablet (1.2 g), so pati...ialisation rights in Italy. Cosmo Pharmaceuticals SpA, Milan, developed the mmx technology. For more information about LIALDA and for Full Prescribing In...
Other Tags
(Date:5/6/2015)... Prime Pacific Health Innovations, the ... announce a new series of universal, one-time-use speculum ... footprint while improving treatment efficacy and saving therapists ... the world’s first waste hose designed specifically for ... claims the company’s president, Mr. Delmar Vogel. , ...
(Date:5/6/2015)... May 06, 2015 “ SideChef ” was featured ... look at the latest and coolest applications on the market for ... technology expert, conducted the app review and shared with viewers how ... the day when to be a good navigator people had to ... and now everyone is a master navigator. Well what if people ...
(Date:5/6/2015)... 2015 vcfo, a specialized consulting firm ... operational support to optimize business performance and productivity, announced ... and Michael Scheaffer. Both Lynch and Scheaffer have more ... , “We are delighted to add Jack and ... “Leveraging their background in financial management and leadership, Mike ...
(Date:5/6/2015)... 2015 Healthcare jobs platform, ... launching in mid-February. The company connects hospitals, home-health, and ... experience in the industry. Likewise, job seekers are able ... Kyle Johnson, CTO, unique traffic to the site is ... "Each new job posting brings targeted, interested candidates to ...
(Date:5/6/2015)... 06, 2015 The Alliance for ... regenerative medicine and advanced therapies community, today announced ... offering an in-depth look at sector trends and ... , The report is available online here ... data points, available here . , Using ...
Breaking Medicine News(10 mins):Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:vcfo Adds Two Senior Executives to Growing Team 2Health News:Job Seekers Turn to JobMedic to Find Healthcare Positions - JobMedic.com Reaches 1,000 User Milestone 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 3
(Date:4/17/2015)... Increasing adoption in ... to drive biometric systems market in ... According to a recently released TechSci Research ... biometric systems market in Saudi Arabia ... CAGR of over 22% through 2020. The market ...
(Date:4/13/2015)... , April 13, 2015 ... TechSci Research, "Global Biometrics Market Forecast & Opportunities, 2020", ... a CAGR of around 14% till 2020. The ... for large scale implementation and review of biometric ... launch of new products with greater efficiency, are ...
(Date:4/9/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ), a ... it will report financial results for the third quarter ... the close of market. The company will host a ... p.m. PT (5:00 p.m. ET), during which management may ... the live call, analysts and investors should dial 888-438-5524 ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2Synaptics to Report Third Quarter Results on April 23 2
Other Contents